Copyright
©The Author(s) 2020.
World J Transplant. Jul 29, 2020; 10(7): 191-205
Published online Jul 29, 2020. doi: 10.5500/wjt.v10.i7.191
Published online Jul 29, 2020. doi: 10.5500/wjt.v10.i7.191
Table 2 Meta-analysis of 4810 ABO incompatibility kidney transplants, grade evidence profile of studies for patient and graft survival after preconditioning therapies[40]
| Risk of bias/quality of evidence | Consistency | Directness | Precision | Publication bias | Overall survival probability | Quality of evidence | |
| Apheresis: 21 (12 cohort studies; 1 case-control; 8 case series) | No serious risk of bias; lack RCTs | Some inconsistency | Direct | No serious imprecision | Suspected publication bias | Patient survival 93.5% | Very low |
| Immunoadsorption: 4 (3 cohort studies; 1 case series) | No serious risk of bias; Lack of RCTs | No inconsistency | -1 | No serious imprecision | No important publication bias | Patient survival 96.4% | Very low |
| Splenectomy: 12 (9 cohort studies; 3 case series) | No serious risk of bias; Lack of RCTs | Some inconsistency | Direct | No serious imprecision | Suspected publication bias | Patient survival 91% | Very low |
| Rituximab: 17 (11 cohort studies; 6 case series) | No serious risk of bias; Lack of RCTs | No inconsistency | Direct | No serious imprecision | Suspected publication bias | Patient survival 96.2% | Very low |
- Citation: Salvadori M, Tsalouchos A. Current protocols and outcomes of ABO-incompatible kidney transplantation. World J Transplant 2020; 10(7): 191-205
- URL: https://www.wjgnet.com/2220-3230/full/v10/i7/191.htm
- DOI: https://dx.doi.org/10.5500/wjt.v10.i7.191